rivastigmine has been researched along with Schizophrenia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Chen, Y; Liu, BF; Liu, X; Qiu, Y; Xu, X; Yu, M; Zhang, G; Zhang, L; Zhang, Y | 1 |
| Chen, Y; Gao, L; Hu, J; Huang, L; Song, T; Yin, L; Zhang, X | 1 |
| Chao, PC; Li, JC; Yeh, CB; Yeh, TC | 1 |
| Budni, J; de Oliveira, MB; Deroza, PF; Fraga, DB; Heylmann, AS; Julião, RF; Luca, RD; Pacheco, FD; Quevedo, J; Volpato, AM; Zugno, AI | 1 |
| Attard, A; Jacobsen, P; Patel, SS; Shergill, S | 2 |
| Jayaram, MB; Kour, K; Singh, J | 1 |
| Bohiri, Y; Kotler, M; Mendelsohn, E; Rosenthal, M; Strous, RD; Werber, E | 1 |
| Chandrasekaran, R; Raguraman, J; Sagar, JV | 1 |
| Aasen, I; Kumari, V; Sharma, T | 1 |
| Aasen, I; ffytche, D; Kumari, V; Sharma, T; Williams, SC | 1 |
| Bentaleb, LA; Chouinard, S; Godbout, R; Guillem, F; Lalonde, P; Melun, P; Poulin, J; Stip, E | 1 |
| Aasen, I; Kumari, V; Reed, C; Sharma, T | 1 |
| Chouinard, S; Cohen, H; Godbout, R; Guillem, F; Melun, JP; Poulin, J; Stip, E | 1 |
| Kircher, T; Leucht, S; Thienel, R; Voss, B | 1 |
3 review(s) available for rivastigmine and Schizophrenia
| Article | Year |
|---|---|
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a review of the literature.
Topics: Cholinesterase Inhibitors; Donepezil; Galantamine; Hallucinations; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
Acetylcholinesterase inhibitors for schizophrenia.
Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Psychotic Disorders; Randomized Controlled Trials as Topic; Rivastigmine; Schizophrenia; Schizophrenic Psychology | 2012 |
[Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].
Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Physostigmine; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2008 |
6 trial(s) available for rivastigmine and Schizophrenia
| Article | Year |
|---|---|
Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily living.
Topics: Activities of Daily Living; Aged; Behavior; Cholinesterase Inhibitors; Chronic Disease; Cognition; Dementia; Female; Humans; Male; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Sex Factors; Treatment Outcome | 2004 |
Effects of rivastigmine on sustained attention in schizophrenia: an FMRI study.
Topics: Adult; Antipsychotic Agents; Attention; Cerebral Cortex; Cholinesterase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Evoked Potentials, Visual; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Phenylcarbamates; Rivastigmine; Schizophrenia; Schizophrenic Psychology | 2005 |
Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study.
Topics: Adult; Antipsychotic Agents; Brain; Cerebral Cortex; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Models, Statistical; Neuroprotective Agents; Phenylcarbamates; Psychiatric Status Rating Scales; Reaction Time; Rivastigmine; Schizophrenia; Smoking | 2006 |
Are cholinergic enhancers beneficial for memory in schizophrenia? An event-related potentials (ERPs) study of rivastigmine add-on therapy in a crossover trial.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cross-Over Studies; Electroencephalography; Evoked Potentials; Female; Humans; Male; Memory Disorders; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine; Schizophrenia; Schizophrenic Psychology | 2006 |
Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Phenylcarbamates; Physostigmine; Psychomotor Performance; Rivastigmine; Schizophrenia; Severity of Illness Index; Verbal Behavior | 2006 |
Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
Topics: Adolescent; Adult; Antipsychotic Agents; Cognition Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroprotective Agents; Phenylcarbamates; Probability; Reference Values; Risk Assessment; Rivastigmine; Schizophrenia; Severity of Illness Index; Treatment Outcome | 2007 |
6 other study(ies) available for rivastigmine and Schizophrenia
| Article | Year |
|---|---|
Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics.
Topics: Animals; Antipsychotic Agents; Body Weight; Chemistry Techniques, Synthetic; Drug Design; Ether-A-Go-Go Potassium Channels; Heterocyclic Compounds; Memory; Mice; Piperazine; Rats; Schizophrenia; Structure-Activity Relationship; Tissue Distribution | 2018 |
Synthesis and pharmacological evaluation of piperidine (piperazine)-amide substituted derivatives as multi-target antipsychotics.
Topics: Amides; Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Humans; Ligands; Molecular Structure; Piperazine; Piperidines; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Schizophrenia; Structure-Activity Relationship | 2020 |
A very low dose of rivastigmine-induced Pisa syndrome in a clozapine-treated patient.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Clozapine; Drug Therapy, Combination; Dystonic Disorders; Female; Humans; Rivastigmine; Schizophrenia | 2018 |
Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Brain; Cholinesterase Inhibitors; Cognition Disorders; Electroshock; Excitatory Amino Acid Antagonists; Ketamine; Male; Memory; Memory, Short-Term; Motor Activity; Neuroprotective Agents; Phenylcarbamates; Rats; Rats, Wistar; Rivastigmine; Schizophrenia; Schizophrenic Psychology | 2013 |
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Drug Resistance; Female; Hallucinations; Humans; Phenylcarbamates; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
Effects of rivastigmine in a case of residual schizophrenia.
Topics: Cholinesterase Inhibitors; Cognition; Female; Humans; Middle Aged; Phenylcarbamates; Quality of Life; Rivastigmine; Schizophrenia | 2005 |